Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 20/20 | 1.00 |
| ▸ | BMX | P51813 | 4/20 | 0.85 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.85 |
| ▸ | ABL1 | P00519 | 3/20 | 0.85 |
| ▸ | YES1 | P07947 | 3/20 | 0.85 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.80 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.80 |
| ▸ | MAP3K7 | O43318 | 2/20 | 0.80 |
| ▸ | EGFR | P00533 | 2/20 | 0.80 |
| ▸ | RAF1 | P04049 | 2/20 | 0.80 |
| ▸ | FYN | P06241 | 2/20 | 0.80 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.80 |
| ▸ | BRAF | P15056 | 2/20 | 0.80 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.80 |
| ▸ | EPHB2 | P29323 | 2/20 | 0.80 |
| ▸ | KDR | P35968 | 2/20 | 0.80 |
| ▸ | BLK | P51451 | 2/20 | 0.80 |
| ▸ | DDR1 | Q08345 | 2/20 | 0.80 |
| ▸ | DDR2 | Q16832 | 2/20 | 0.80 |
| ▸ | IKBKB | O14920 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17935965 | 0.99 | SRC (1.00) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17936128 | 0.95 | SRC (1.00) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17936061 | 0.92 | SRC (1.00) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17936071 | 0.92 | SRC (1.00) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17936118 | 0.92 | SRC (1.00) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17936116 | 0.91 | SRC (0.84) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17935961 | 0.91 | SRC (0.84) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17935966 | 0.91 | SRC (1.00) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17935959 | 0.89 | SRC (1.00) | SRCBMXNTRK1ABL1YES1 | |
| SCHEMBL17936038 | 0.88 | SRC (0.95) | SRCBMXNTRK1ABL1YES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10266537-B2 | 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof | St. Chuan University (CN) | 2019-04-23 | — | — | US | disclosed |
| US-20170305920-A1 | 3-ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USES THEREOF | SI CHUAN UNIVERSITY (CN) | 2017-10-26 | — | — | US | disclosed |
| US-20170305920-A1 | 3-ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USES THEREOF | SI CHUAN UNIVERSITY (CN) | 2017-10-26 | — | — | US | disclosed |
| WO-2016112846-A1 | 3-ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USES THEREOF | 四川大学 | 2016-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170305920-A1 | 3-ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USES THEREOF | DPYD, TYMP, WEE1 | SRC 1111/4885BMX 2512/4885NTRK1 3602/4885 |
| US-10266537-B2 | 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof | DPYD, TYMP, WEE1 | SRC 1111/4885BMX 2512/4885NTRK1 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.